The views presented in On Balance are those of the authors and do not represent the views of the Society, its Board, or its members.
This post is part of a series on President Trump’s deregulatory record and what we might expect in the new administration.
Benefit-cost analysis has been part of the U.S. regulatory development process for over 40 years. The historic record, when coupled with recent actions, raises questions about its continued role ‒ in particular whether the focus will shift increasingly to considering costs without comparison to benefits.